Lunan New Media      Yu Jie, Duan Yuqing      27th December 2019

On 23rd December, Lunan Better Pharmaceutical Limited, a subsidiary company of Lunan Pharmaceutical Group Co., Ltd, received the approval for the consistency evaluation of Cetirizine Hydrochloride Tablet (Brand name: Bei Fen, specification: 10mg) issued by NMPA, Bei Fen®: Cetirizine Hydrochloride Tablet was also approved to be an OTC drug. This is the third drug variety of Lunan Better Pharmaceutical Limited that passed the consistency evaluation, Rui Zhi® and Xin Kang® are another two drug varieties that passed the consistency evaluation earlier. 

Cetirizine Hydrochloride Tablet is the main product of anti-allergy drugs of Lunan Pharmaceutical, which obtained the new drug certificate and production approval on 27th May, 2000, mainly used for seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergic itching and urticaria. 

Lunan Pharmaceutical has been adhering to the purpose of "Benefit the society, create a better life", to provide customers the high quality drugs with spirit of craftsmanship. We firmly control every step for a safe, high quality and effective production, so as to better meet the needs of the patients and clinical treatment in terms of both quality and price.

The author(Chinese version): Wang Ying